Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Radiother ; 15(2): 89-96, 2011 Apr.
Artigo em Francês | MEDLINE | ID: mdl-20674447

RESUMO

PURPOSE: Surgery is the treatment of choice for localized uterine sarcomas. We conducted a retrospective study to define prognostic factors. PATIENTS AND METHODS: We studied 111 cases of patients treated by adjuvant radiotherapy for uterine sarcoma in seven French centers. The median decline was 31 months. We conducted a univariate analysis to identify factors correlated with local recurrence. The statistically significant factors were studied in multivariate analysis by Cox model. RESULTS: The median dose of external beam radiotherapy was 45 Gy. Forty-three percent of patients had vaginal vault brachytherapy and 21 % chemotherapy. Only 6.3 % of patients had complications of acute grade III and 8.1 % of long-term sequelae of radiotherapy. The survival rate at 5 years was 74.6 %. They noted 12.6 % of isolated locoregional recurrences, against 29.7 % for distant recurrences, 80 % were pulmonary. Factors correlated with the risk of locoregional relapse were menopausal status (P = 0.045) and surgical margins suspicious or not healthy (P = 0.0095). The chemotherapy did not improve overall survival or disease free survival but the numbers were low. CONCLUSION: The postoperative radiotherapy provides good local control in this disease. Brachytherapy is sometimes done, but it does not improve local control. Chemotherapy is not a standard localized stage but the rate of metastatic recurrence calls for the development of strategies involving systemic treatment with radiotherapy.


Assuntos
Carcinossarcoma/radioterapia , Tumores do Estroma Endometrial/radioterapia , Leiomiossarcoma/radioterapia , Neoplasias Uterinas/radioterapia , Análise de Variância , Braquiterapia/efeitos adversos , Braquiterapia/métodos , Braquiterapia/estatística & dados numéricos , Carcinossarcoma/mortalidade , Carcinossarcoma/patologia , Carcinossarcoma/secundário , Carcinossarcoma/terapia , Terapia Combinada/métodos , Tumores do Estroma Endometrial/mortalidade , Tumores do Estroma Endometrial/patologia , Tumores do Estroma Endometrial/secundário , Tumores do Estroma Endometrial/terapia , Feminino , França , Humanos , Histerectomia/métodos , Leiomiossarcoma/mortalidade , Leiomiossarcoma/patologia , Leiomiossarcoma/secundário , Leiomiossarcoma/terapia , Neoplasias Pulmonares/secundário , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/mortalidade , Recidiva Local de Neoplasia/patologia , Prognóstico , Modelos de Riscos Proporcionais , Radioterapia/efeitos adversos , Dosagem Radioterapêutica , Estudos Retrospectivos , Análise de Sobrevida , Neoplasias Uterinas/mortalidade , Neoplasias Uterinas/patologia , Neoplasias Uterinas/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...